x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2014 > Visiting Professorship on Renal Cancer
Print

Visiting Professorship on Renal Cancer

6 ESCO credits

11.12.2014  -  12.12.2014

Budapest, Hungary

COURSES AND SEMINARS

General oncology

Description

Visiting Professor: C. Porta, IT
Host Chair: M. Dank, HU

General information

ORGANISING SECRETARIAT
Roberta Ventura
European School of Oncology
Via Turati, 29 - 20121 Milan, Italy
Email: rventura@eso.net
Tel: +39 028546 4532


VENUE

Semmelweis University
Department of Urology and Uro-oncology
1082. Budapest Üllöi út 78/B
Hungary


OFFICIAL LANGUAGE

The official language will be English. No translation will be provided.


INSURANCE

The organisers bear no responsibility for on toward events in relation to the participation in
the event. Participants are advised to take out their own personal and travel insurance
coverage.


CERTIFICATE OF ATTENDANCE

All participants will be issued a certificate of attendance at the close of the event.


SHARING PROGRESS IN CANCER CARE

Sharing Progress in Cancer Care programme (SPCC) is a pioneering partnership between the European School of Oncology and some of the world’s leading pharmaceutical companies.
GlaxoSmithKline, sustaining member of the SPCC programme, has provided a grant towards ESO for this programme. GlaxoSmithKline has exercised no, and has no right to exercise any, editorial control
over the programme, its content or speakers.


.

Faculty list


FACULTY
C. Porta, IRCCS Policlinico San Matteo, Pavia, IT
M. Dank, Semmelweis Univesity, Budapest, HU

 

.

Programme


11 December

   
 14:00  Welcome lunch and registration
 14:30 Approach to diagnosis and treatment, Presentations by the Heads of Departments
 15:30 Discussion
 15:45 Coffee break
16:00
Surgery in RCC
P. Nyírádi, HU
16:20
The treatment of advanced RCC: from first-line to …
C. Porta, IT
17:20
Clinical cases presented by Departments of Semmelweis University
18:20
-18:45

Discussion



 

12 December

   
9:00 Novelties in the pathogenesis of RCC leading to new therapeutic approaches: a glowing glance into the crystal ball
C. Porta, IT
10:00
 Coffee break
10:30
 Clinical cases presented by Departments of Semmelweis University
11:30
 Adjuvant and neo-adjuvant treatment for RCC
C. Porta, IT
12:00
-12:30
 Discussion and closing remarks
   
   
   
   
   
   
   

Follow us